ロング

CWBR CohBar retracement completed ! Buy opportunity?

CWBR CohBar is developing mitochondria based therapeutics for the treatment of age-related diseases.
So it`s an anti-aging listed companies.
They released positive topline results from an early stage study into CB4211, a drug under development for the treatment of nonalcoholic steatohepatitis, but after a 70% increase, the stock went even lower than before the pump.

WBB Securities upgraded CohBar, Inc. stock to Buy from Speculative Buy with a price target of $5.

On 4/23/2021 Maxim Group brokerage Initiated Coverage with a Buy rating and a price target of $3.00

The Market Cap is only 72.138M

I see a lot of potential in this stock! Do you?

TopgOptions

DAILY PRIVATE HIGH-CONVICTION OPTIONS SIGNALS: patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/

他のメディア:

免責事項

これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。

TopgOptions

他のメディア: